S1917 Incidence and Predictors of Hospital Readmission for Ulcerative Colitis

Introduction: Over 3 million individuals in the United States live with inflammatory bowel disease, with approximately half affected by ulcerative colitis (UC). About 50% of UC patients require at least one disease-related hospitalization, and up to 20% may be readmitted within 30 days. Existing U.S.-based studies are limited by small sample sizes, poor generalizability, and lack of granular data on index hospitalizations and follow-up care. Methods: We conducted a retrospective cohort study of adults hospitalized with a primary diagnosis of UC between January 2010 and September 2023 within a large integrated healthcare system serving over 4.5 million individuals. We evaluated the incidence of all-cause 30-day readmissions and identified predictors by analyzing patient characteristics, hospitalization details, post-discharge care, and maintenance UC therapy changes. Results: The cohort included 942 patients (mean age 46.2 years; 50.5% women; 57% White). Of these, 151 patients (16%) were readmitted within 30 days. Univariate analysis showed readmitted patients had lower albumin levels at index admission (2.7 vs 2.9 g/dL, P < 0.05) and longer length of stay (6.8 vs 5.5 days, P < 0.05). Post-discharge, readmitted patients were less likely to follow up within 30 days with gastroenterology (26% vs 70%, P < 0.001) or a primary care provider (39% vs 77%, P < 0.001). They were also less likely to have a major change in UC therapy, defined as initiation of a new treatment (10% vs 32%). Multivariate analysis, adjusted for demographics, comorbidities, medications, and follow-up, found that malnutrition (OR 1.9, 95% CI 1.2–3.2, P = 0.01), lack of GI follow-up (odds ratio [OR] 5.3, 95% CI 3.4–8.3, P < 0.01), and lack of PCP follow-up (OR 4.2, 95% CI 2.8–6.5, P < 0.01) were significantly associated with 30-day readmission. A major change in UC therapy was protective (OR 3.1, 95% CI 1.6–6.1, P = 0.001). Conclusion: Patients hospitalized for UC face high 30-day readmission rates. While clinical factors such as malnutrition and longer index hospitalization are predictive, timely post-discharge interventions—including GI and PCP follow-up and UC treatment modification—may significantly reduce readmissions.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001135128.98330.4f
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S1917 Incidence and Predictors of Hospital Readmission for Ulcerative Colitis

Fernando Velayos, Jennifer Chan, Abhik Roy, Belia O. Roybal
The American Journal of Gastroenterology
Inflammatory Bowel Disease
article

S1917 Incidence and Predictors of Hospital Readmission for Ulcerative Colitis

Fernando Velayos, Jennifer Chan, Abhik Roy, Belia O. Roybal
article en

Abstract

Introduction: Over 3 million individuals in the United States live with inflammatory bowel disease, with approximately half affected by ulcerative colitis (UC). About 50% of UC patients require at least one disease-related hospitalization, and up to 20% may be readmitted within 30 days. Existing U.S.-based studies are limited by small sample sizes, poor generalizability, and lack of granular data on index hospitalizations and follow-up care. Methods: We conducted a retrospective cohort study of adults hospitalized with a primary diagnosis of UC between January 2010 and September 2023 within a large integrated healthcare system serving over 4.5 million individuals. We evaluated the incidence of all-cause 30-day readmissions and identified predictors by analyzing patient characteristics, hospitalization details, post-discharge care, and maintenance UC therapy changes. Results: The cohort included 942 patients (mean age 46.2 years; 50.5% women; 57% White). Of these, 151 patients (16%) were readmitted within 30 days. Univariate analysis showed readmitted patients had lower albumin levels at index admission (2.7 vs 2.9 g/dL, P < 0.05) and longer length of stay (6.8 vs 5.5 days, P < 0.05). Post-discharge, readmitted patients were less likely to follow up within 30 days with gastroenterology (26% vs 70%, P < 0.001) or a primary care provider (39% vs 77%, P < 0.001). They were also less likely to have a major change in UC therapy, defined as initiation of a new treatment (10% vs 32%). Multivariate analysis, adjusted for demographics, comorbidities, medications, and follow-up, found that malnutrition (OR 1.9, 95% CI 1.2–3.2, P = 0.01), lack of GI follow-up (odds ratio [OR] 5.3, 95% CI 3.4–8.3, P < 0.01), and lack of PCP follow-up (OR 4.2, 95% CI 2.8–6.5, P < 0.01) were significantly associated with 30-day readmission. A major change in UC therapy was protective (OR 3.1, 95% CI 1.6–6.1, P = 0.001). Conclusion: Patients hospitalized for UC face high 30-day readmission rates. While clinical factors such as malnutrition and longer index hospitalization are predictive, timely post-discharge interventions—including GI and PCP follow-up and UC treatment modification—may significantly reduce readmissions.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 59%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.